Deletion of Ribosomal S6 Kinases Does Not Attenuate Pathological, Physiological, or Insulin-Like Growth Factor 1 Receptor-Phosphoinositide 3-Kinase-Induced Cardiac Hypertrophy

Documenti analoghi

• Correction for McMullen et al., “Deletion of Ribosomal S6 Kinases Does Not Attenuate Pathological, Physiological, or Insulin-Like Growth Factor 1 Receptor–Phosphoinositide 3-Kinase-Induced Cardiac Hypertrophy”
  di: McMullen, Julie R., et al.
  Pubblicazione: (2021)
• Phosphoinositide 3-kinase(p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy
  di: McMullen, Julie R., et al.
  Pubblicazione: (2003)
• Class I(A) Phosphoinositide 3-Kinase Regulates Heart Size and Physiological Cardiac Hypertrophy
  di: Luo, Ji, et al.
  Pubblicazione: (2005)
• Phosphoinositide 3-kinase Akt signaling pathway interacts with protein kinase Cβ2 in the regulation of physiologic developmental hypertrophy and heart function
  di: Rigor, Debra L., et al.
  Pubblicazione: (2009)
• The conserved phosphoinositide 3-kinase pathway determines heart size in mice
  di: Shioi, Tetsuo, et al.
  Pubblicazione: (2000)